MTOR and cancer: Genomic analysis showed that mutations in RHOA in cancer cells (which promote tumor progression) activate the PI3K-AKT-mTOR signaling pathway, increasing the production of free fatty acids that are consumed more efficiently by Treg cells than Teff cells.